Longeveron’s Laromestrocel for Frailty: Breaking Down Cell Stem Cell Data & Problematic Nature Coverage

by rss feed | Mar 4, 2026 | journal club, laromestrocel, Longeveron, mesenchymal cells, MSCs frailty, News Feeds

Longeveron is a biotech studying clinical applications of mesenchymal stromal/stem cells or MSCs . MSCs are interesting, usually heterogeneous cell preparations. They are probably most well known for modulating the behavior of other cells via their secretome. The...

Weekly reads: stem cells everywhere, MSCs for MS?, nanostickers, Makary update

by rss feed | May 11, 2025 | mesenchymal cells, nanostickers, News Feeds, weekly reads

It was another crazy week for me with tons of grant work, but news  and research in the regenerative medicine world keep on popping up including a paper on MSCs for MS. I’ve realized that even when I’m trying to take a short break, I often see science and...

In landmark, FDA approves first MSC therapy, Mesoblast’s Ryoncil for GvHD

by rss feed | Dec 18, 2024 | mesenchymal cells, Mesoblast, News Feeds, Remestemcel-l, RYONCIL

In a landmark decision, today the FDA approved Ryoncil from Mesoblast for GvHD. This is the first time the FDA has approved a mescenchymal stromal/stem cell or MSC therapy of any kind. There have been many ups and downs for Mesoblast toward this approval of Ryoncil or...

Hoping for approval, Mesoblast says FDA wants new remestemcel-L trial

by rss feed | Aug 4, 2023 | clinical trials, mesenchymal cells, Mesoblast, News Feeds, Remestemcel-l

Australian biotech Mesoblast has had a rollercoaster ride working toward FDA approval of its mesenchymal cell therapy product remestemcel-L. They are seeking approval for use in patients with graft-versus-host disease (GvHD). More specifically, it is intended for...

Weekly reads: MSC, p53, EuroGCT, fake fish, K27M CAR-T

by rss feed | Feb 13, 2022 | mesenchymal cells, MSC, News Feeds

What exactly is a mesenchymal cell and what does the acronym MSC stand for these days? I took a stab recently at discussing mesenchymal cells and the MSC acronym so check that out. There is a great need for standards on MSCs and the products out there being marketed...

Boning up on stem cells for osteoporosis: good idea, little data so far

by rss feed | Sep 22, 2021 | Fact-check, mesenchymal cells, News Feeds, Osteoporosis

It’s great when an idea like stem cells for osteoporosis just makes so much common sense, but it still requires data. A logical hypothesis is not enough. The point of today’s post is to fact-check the idea of using stem cells for such bone loss. A femur to...